公司概覽
業務類別 --
業務概覽 Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease. Its product, KidneyIntelX, is designed to improve kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company's service, KidneyIntelX.dkd, enables the assessment of risk for early-stage chronic kidney disease progression. KidneyIntelX uses a proprietary algorithm combining blood-based biomarkers, inherited genetics, and electronic health record data to generate a patient risk score predicting rapid kidney function decline.
公司地址 2 Leman Street, London, GBR, E1W 9US
電話號碼 +44 2079338790
傳真號碼 --
公司網頁 https://www.renalytix.com
員工數量 46
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Fergus Fleming Executive Director,Chief Technical Officer 美元 311.00K 09/12/2025
Mr. James Renwick McCullough Executive Director,Chief Executive Officer 美元 427.00K 09/12/2025
Mr. Salim Hamir Company Secretary -- 30/12/2025
 
董事會成員
董事會 職務 更新日期
Mr. Christopher Harwood Bernard Mills Non-Executive Director 09/12/2025
Mr. Julian Huw Baines MBE Non-Executive Director,Chairman 30/12/2025
Mr. Fergus Fleming Executive Director,Chief Technical Officer 09/12/2025
Mr. James Renwick McCullough Executive Director,Chief Executive Officer 09/12/2025
Mr. Robert Graham Naylor Non-Executive Director 09/12/2025
Ms. Catherine Havlik Coste Non-Executive Director 30/12/2025
Dr. Erik Lium Non-Executive Director 09/12/2025
 
所屬ETF (更新日期: 28/02/2026 05:21)
代號 名稱 佔比% 持有日期
THWabrdn World Healthcare4.07%31/01/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.